Tumor Surgery


Bladder tumors, prostate tumors or partial nephrectomy – biolitec® offers safe and effective applications to meet the requirements of modern laser surgery for both.

 

TULA® - Bladder tumors

The ability of simultaneous vaporization and coagulation offers a simple and safe method with a minimal to non loss of blood. The laser procedure can be performed on an outpatient basis under local anesthesia or even without anesthesia and offers the advantage over the previous standard procedure that general anesthesia can be omitted.

Non-muscle invasive bladder tumor normally has a high recurrence rate, leading to multiple treatments. Elderly patients with multiple morbidities are not fit for conventional treatment under general anesthesia. TULA® DUAL offers a technique using flexible cystoscopy for the treatment of bladder tumor under local or even no anesthesia in outpatient settings.

 

FLA with Prostate tumors

The combination of real-time prostate Magnetic Resonance Imaging (MRI) and thermometry with Focal Laser Ablation (FLA) has led to a new and higher quality of prostate tumor treatment. Now selected patients diagnosed with low to intermediate localized prostate tumors can be treated safely and very precisely without collateral damage to sensitive structures.

After confirmed diagnosis with PSA blood tests, MRI scans and a prostate biopsy, the Litt, Litt2B or 3B fiber of the biolitec® is gently under MRI and thermometry guidance introduced and positioned into the core of the tumor. When the LEONARDO® DUAL 45 laser is activated, the Litt2B or 3B fiber tip destroys the tumor with a round- or olive-shaped ablation zone, within minutes.

 

Partial nephrectomy

The properties of our high-tech optical fibers contribute to a successful nephron sparing surgery securing better overall renal function and make them the fibers of choice to ensure best results. Cutting and coagulating at the same time provides minimal bleeding with a good view on the tissue. Our special diode lasers for partial nephrectomy offer the benefit of no or shorter warm ischemia time with more effective tissue coagulation, hemostasis and reduced parenchymal damage.